First report of mefA and msrA/msrB multidrug efflux pumps associated with blaTEM-1 β-lactamase in Enterococcus

Chedly Chouchani1, Allaaeddin El Salabi, Rim Marrakchi

  • 1Université de Carthage, Institut Supérieur des Sciences et Technologies de l'Environnement de Borj-Cedria, Technopôle de Borj-Cedria, BP-1003, Hammam-Lif 2050, Tunisia. chdoula77@yahoo.fr

Abstract

Insights

This study identified TEM-1 beta-lactamase and mefA/msrA/msrB efflux pumps as resistance mechanisms in clinical Enterococcus faecalis isolates. This is the first report of these two mechanisms co-existing in E. faecalis strains.

Area of Science:

  • Microbiology
  • Antimicrobial Resistance
  • Molecular Biology

Background:

  • Enterococcus faecalis exhibits significant intrinsic resistance to various antimicrobial agents.
  • Understanding resistance mechanisms is crucial for effective treatment strategies.

Purpose of the Study:

  • To identify ampicillin- and erythromycin-resistant clinical isolates of E. faecalis.
  • To elucidate the specific resistance mechanisms employed by these isolates.

Main Methods:

  • Phenotypic identification and susceptibility testing using the Phoenix automated system.
  • PCR amplification and sequencing for beta-lactamase detection.
  • Colony blotting and protein sequencing to identify multidrug efflux pumps.

Main Results:

  • All E. faecalis isolates demonstrated high resistance to erythromycin and ampicillin (MIC >16 μg/ml).
  • TEM-1 beta-lactamase production was confirmed via PCR and sequencing.
  • The mefA and msrA/msrB efflux pumps were identified as contributing to multidrug resistance.

Conclusions:

  • The study identified TEM-1 beta-lactamase and mefA/msrA/msrB efflux pumps as key resistance mechanisms in E. faecalis.
  • This is the first documented instance of the co-existence of these two resistance mechanisms in E. faecalis strains.
  • These findings highlight the evolving resistance landscape of E. faecalis.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...